Prescribing naloxone for opioid overdose intervention

Area of Science:

• Pharmacology
• Public Health
• Emergency Medicine

Background:

• Opioid overdose deaths remain a critical public health issue.
• Naloxone is a vital medication for reversing opioid overdoses.
• Current naloxone prescribing practices often miss opportunities for wider community distribution.

Purpose of the Study:

• To review current naloxone prescribing practices as a harm-reduction strategy.
• To identify opportunities for expanding naloxone access and use in the community.
• To highlight the role of naloxone in reducing opioid overdose fatalities.

Main Methods:

• A PubMed search was conducted to identify relevant publications on naloxone prescribing.
• The review focused on naloxone's role in opioid overdose reversal and harm reduction.
• Analysis of available literature on FDA-approved naloxone formulations and community use.

Main Results:

• New FDA-approved naloxone formulations (intranasal spray, autoinjector) are available for community use.
• Significant opportunities to expand naloxone prescribing are often underutilized.
• Effective community naloxone programs require patient/family screening, education, and training.

Conclusions:

• Expanded naloxone prescribing and community distribution are crucial for harm reduction.
• Available tools and formulations present a significant opportunity to decrease opioid overdose deaths.
• Systematic implementation of naloxone prescribing protocols can save lives.